Insufficient scRNA-seq data for expression of ANGPTL7 at single-cell level.
Insufficient scRNA-seq data for expression of ANGPTL7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 58% | 457.07 | 142 / 245 | 72% | 3.79 | 363 / 502 |
| skin | 48% | 363.72 | 873 / 1809 | 68% | 49.35 | 320 / 472 |
| adrenal gland | 46% | 177.42 | 118 / 258 | 52% | 6.78 | 120 / 230 |
| blood vessel | 87% | 1220.89 | 1156 / 1335 | 0% | 0 | 0 / 0 |
| breast | 69% | 575.52 | 318 / 459 | 15% | 0.81 | 166 / 1118 |
| bladder | 67% | 407.14 | 14 / 21 | 10% | 0.34 | 49 / 504 |
| esophagus | 64% | 743.84 | 924 / 1445 | 8% | 0.34 | 15 / 183 |
| intestine | 57% | 529.24 | 554 / 966 | 9% | 0.35 | 45 / 527 |
| adipose | 64% | 1226.09 | 768 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 1% | 1.80 | 2 / 328 | 55% | 3.92 | 98 / 178 |
| eye | 0% | 0 | 0 / 0 | 53% | 1.95 | 42 / 80 |
| heart | 46% | 311.77 | 399 / 861 | 0% | 0 | 0 / 0 |
| stomach | 31% | 203.84 | 110 / 359 | 15% | 0.63 | 43 / 286 |
| kidney | 25% | 231.76 | 22 / 89 | 15% | 1.63 | 131 / 901 |
| muscle | 35% | 490.45 | 284 / 803 | 0% | 0 | 0 / 0 |
| uterus | 24% | 119.94 | 41 / 170 | 8% | 1.78 | 36 / 459 |
| lung | 22% | 59.53 | 128 / 578 | 10% | 0.38 | 111 / 1155 |
| brain | 17% | 66.84 | 439 / 2642 | 4% | 0.21 | 27 / 705 |
| thymus | 11% | 57.41 | 73 / 653 | 3% | 0.19 | 19 / 605 |
| ovary | 6% | 32.86 | 11 / 180 | 2% | 0.43 | 9 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.07 | 2 / 45 |
| liver | 0% | 0 | 0 / 226 | 4% | 1.43 | 16 / 406 |
| spleen | 1% | 2.44 | 3 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 2.10 | 4 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1901346 | Biological process | negative regulation of vasculature development involved in avascular cornea development in camera-type eye |
| GO_0006979 | Biological process | response to oxidative stress |
| GO_1903053 | Biological process | regulation of extracellular matrix organization |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ANGPTL7 |
| Protein name | Angiopoietin-related protein 7 (Angiopoietin-like factor) (Angiopoietin-like protein 7) (Cornea-derived transcript 6 protein) |
| Synonyms | UNQ313/PRO356 CDT6 |
| Description | FUNCTION: Has a role in the formation and organization of the extracellular matrix. In the eye, it functions as a mediator of dexamethasone-induced matrix deposition in the trabecular meshwork, the tissue responsible for the outflow of the ocular aqueous humor and for the maintenance of intraocular pressure . Is a negative regulator of angiogenesis in the cornea, and plays a major role in maintaining corneal avascularity and transparency . . |
| Accessions | ENST00000376819.4 O43827 |